In contrast, impaired liver function would be expected to cause GH resistance rather than reduced GH, supporting the possibility that reduced GH secretory capacity found in individuals with NAFLD may contribute to NAFLD onset and progression. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.